Literature DB >> 15161688

Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor.

Robert A Nordal1, Andras Nagy, Melania Pintilie, C Shun Wong.   

Abstract

PURPOSE: Microvascular permeability changes and loss of blood-brain barrier integrity are important features of central nervous system (CNS) radiation injury. Expression of vascular endothelial growth factor (VEGF), an important determinant of microvascular permeability, was examined to assess its role in CNS radiation damage. Because hypoxia mediates VEGF up-regulation through hypoxia-inducible factor-1alpha (HIF1alpha) induction, we studied the relationships of hypoxia, HIF1alpha expression, and expression of VEGF in this damage pathway. EXPERIMENTAL
DESIGN: Expression of HIF1alpha, VEGF, and another hypoxia-responsive gene, glucose transporter-1, was assessed in the irradiated rat spinal cord using immunohistochemistry and in situ hybridization. Hypoxic areas were identified using the nitroimidazole 2-(2-nitro-1H-imidazole-L-yl)-N-(2,2,3,3,3,-pentafluoropropyl) acetamide. To determine the causal importance of VEGF expression in radiation myelopathy, we studied the response of transgenic mice with greater (VEGF-A(hi/+)), reduced (VEGF-A(lo/+)), and wild-type VEGF activity to thoracolumbar irradiation.
RESULTS: In rat spinal cord, the number of cells expressing HIF1alpha and VEGF increased rapidly from 16 to 20 weeks after radiation, before white matter necrosis and forelimb paralysis. A steep dose response was observed in expression of HIF1alpha and VEGF. HIF1alpha and VEGF expressing cells were identified as astrocytes. Hypoxia was present in regions where up-regulation of VEGF and glucose transporter-1 and increased permeability was observed. VEGF-A(lo/+) mice had a longer latency to development of hindlimb weakness and paralysis compared with wild-type or VEGF-A(hi/+) mice.
CONCLUSIONS: VEGF expression appears to play an important role in CNS radiation injury. This focuses attention on VEGF and other genes induced in response to hypoxia as targets for therapy to reduce or prevent CNS radiation damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161688     DOI: 10.1158/1078-0432.CCR-03-0426

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  66 in total

1.  Characterization of late radiation effects in the rat thoracolumbar spinal cord by MR imaging using USPIO.

Authors:  M E P Philippens; G Gambarota; J A Pikkemaat; W J M Peeters; A J van der Kogel; A Heerschap
Journal:  MAGMA       Date:  2004-12-21       Impact factor: 2.310

2.  Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Authors:  Ivana K Kim; Anne Marie Lane; Purva Jain; Caroline Awh; Evangelos S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

3.  Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.

Authors:  Nathan A Dahl; Arthur K Liu; Nicholas K Foreman; Melissa Widener; Laura Z Fenton; Margaret E Macy
Journal:  Childs Nerv Syst       Date:  2019-07-31       Impact factor: 1.475

Review 4.  New advances that enable identification of glioblastoma recurrence.

Authors:  Isaac Yang; Manish K Aghi
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

5.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

6.  First-line bevacizumab for glioblastoma: what do recent Trail results mean for future treatment?

Authors:  Christine Marosi
Journal:  CNS Oncol       Date:  2013-11

7.  Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.

Authors:  Mudit Chowdhary; Derick Okwan-Duodu; Jeffrey M Switchenko; Robert H Press; Jaymin Jhaveri; Zachary S Buchwald; Jim Zhong; Bhavana V Chapman; Ranjit S Bindra; Joseph N Contessa; Henry S Park; James B Yu; Roy H Decker; Jeffrey J Olson; Nelson M Oyesiku; Ross A Abrams; Hui-Kuo G Shu; Walter J Curran; Ian R Crocker; Kirtesh R Patel
Journal:  J Neurooncol       Date:  2017-11-09       Impact factor: 4.130

8.  Mitigation of radiation myelopathy and reduction of microglial infiltration by Ramipril, ACE inhibitor.

Authors:  Mariano G Clausi; Alexander M Stessin; Stella E Tsirka; Samuel Ryu
Journal:  Spinal Cord       Date:  2018-06-14       Impact factor: 2.772

Review 9.  Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.

Authors:  Jae Ho Kim; Stephen L Brown; Kenneth A Jenrow; Samuel Ryu
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

10.  Prolonged fasting activates hypoxia inducible factors-1α, -2α and -3α in a tissue-specific manner in northern elephant seal pups.

Authors:  José G Soñanez-Organis; José P Vázquez-Medina; Daniel E Crocker; Rudy M Ortiz
Journal:  Gene       Date:  2013-05-22       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.